Adenofibroma: A benign neoplasm composed of glandular and fibrous tissues, with a relatively large proportion of glands. (Stedman, 25th ed)Dictionaries, MedicalCystadenofibroma: Benign or borderline malignant neoplasm of the ovary and surrounding tissues. It is characterized by tumor(s) with cystic glands which are lined by cuboidal EPITHELIAL CELLS with clear cytoplasm, resembling ENDOMETRIUM cells. The glands are separated by fibroblastic STROMAL CELLS.Dictionaries as Topic: Lists of words, usually in alphabetical order, giving information about form, pronunciation, etymology, grammar, and meaning.Dictionaries, ChemicalCalbindins: Calcium-binding proteins that are found in DISTAL KIDNEY TUBULES, INTESTINES, BRAIN, and other tissues where they bind, buffer and transport cytoplasmic calcium. Calbindins possess a variable number of EF-HAND MOTIFS which contain calcium-binding sites. Some isoforms are regulated by VITAMIN D.S100 Calcium Binding Protein G: A calbindin protein found in many mammalian tissues, including the UTERUS, PLACENTA, BONE, PITUITARY GLAND, and KIDNEYS. In intestinal ENTEROCYTES it mediates intracellular calcium transport from apical to basolateral membranes via calcium binding at two EF-HAND MOTIFS. Expression is regulated in some tissues by VITAMIN D.Calbindin 1: A calcium-binding protein that mediates calcium HOMEOSTASIS in KIDNEYS, BRAIN, and other tissues. It is found in well-defined populations of NEURONS and is involved in CALCIUM SIGNALING and NEURONAL PLASTICITY. It is regulated in some tissues by VITAMIN D.Calbindin 2: A calbindin protein that is differentially expressed in distinct populations of NEURONS throughout the vertebrate and invertebrate NERVOUS SYSTEM, and modulates intrinsic neuronal excitability and influences LONG-TERM POTENTIATION. It is also found in LUNG, TESTIS, OVARY, KIDNEY, and BREAST, and is expressed in many tumor types found in these tissues. It is often used as an immunohistochemical marker for MESOTHELIOMA.Search Engine: Software used to locate data or information stored in machine-readable form locally or at a distance such as an INTERNET site.Databases, Genetic: Databases devoted to knowledge about specific genes and gene products.Genome, Human: The complete genetic complement contained in the DNA of a set of CHROMOSOMES in a HUMAN. The length of the human genome is about 3 billion base pairs.Lipase: An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. It is produced by glands on the tongue and by the pancreas and initiates the digestion of dietary fats. (From Dorland, 27th ed) EC 3.1.1.3.Antibodies: Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).Internet: A loose confederation of computer communication networks around the world. The networks that make up the Internet are connected through several backbone networks. The Internet grew out of the US Government ARPAnet project and was designed to facilitate information exchange.T-Lymphocytes, Regulatory: CD4-positive T cells that inhibit immunopathology or autoimmune disease in vivo. They inhibit the immune response by influencing the activity of other cell types. Regulatory T-cells include naturally occurring CD4+CD25+ cells, IL-10 secreting Tr1 cells, and Th3 cells.Forkhead Transcription Factors: A subclass of winged helix DNA-binding proteins that share homology with their founding member fork head protein, Drosophila.Disclosure: Revealing of information, by oral or written communication.Truth Disclosure: Truthful revelation of information, specifically when the information disclosed is likely to be psychologically painful ("bad news") to the recipient (e.g., revelation to a patient or a patient's family of the patient's DIAGNOSIS or PROGNOSIS) or embarrassing to the teller (e.g., revelation of medical errors).Interleukin-2 Receptor alpha Subunit: A low affinity interleukin-2 receptor subunit that combines with the INTERLEUKIN-2 RECEPTOR BETA SUBUNIT and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN to form a high affinity receptor for INTERLEUKIN-2.CD4-Positive T-Lymphocytes: A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes.T-Lymphocyte Subsets: A classification of T-lymphocytes, especially into helper/inducer, suppressor/effector, and cytotoxic subsets, based on structurally or functionally different populations of cells.Methylation: Addition of methyl groups. In histo-chemistry methylation is used to esterify carboxyl groups and remove sulfate groups by treating tissue sections with hot methanol in the presence of hydrochloric acid. (From Stedman, 25th ed)DNA Methylation: Addition of methyl groups to DNA. DNA methyltransferases (DNA methylases) perform this reaction using S-ADENOSYLMETHIONINE as the methyl group donor.Immune Tolerance: The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc.
(1/127) The expression of CCAAT/enhancer binding protein (C/EBP) in the human ovary in vivo: specific increase in C/EBPbeta during epithelial tumour progression.

The CCAAT/enhancer binding protein (C/EBP) family of transcription factors is involved in metabolism and differentiation of cells, especially in rodent liver cells and adipocytes. Their roles in vivo and in particular during pathophysiological conditions in humans are largely unknown. We have investigated the presence of C/EBPalpha, -beta, -delta and -zeta in normal ovaries and in epithelial ovarian tumours of different stages. Immunohistochemical experiments demonstrated that C/EBPalpha and C/EBPbeta were preferentially expressed in epithelial/tumour cells irrespective of stage or grade of the tumour. C/EBPbeta was located in the nuclei of the cells, in contrast to C/EBPalpha, which was present only in the cytoplasm of these cells. The nuclear localization of C/EBPbeta indicates an active role of this transcription factor in tumour cells, whereas the cytoplasmic distribution suggests a more passive function of C/EBPalpha. C/EBPdelta and -zeta demonstrated a more diverse distribution with predominant localization to epithelial cells, but stromal distribution was also noted. The intracellular distribution was confined to both the nucleus and the cytoplasm for C/EBPdelta and -zeta. Western blotting demonstrated that C/EBPalpha, -beta, -delta and -zeta were present in a majority of the samples. The amount of C/EBPbeta increased markedly with malignancy, i.e. with degree of dedifferentiation, while the other members of the C/EBP family displayed a more constant expression level. These results demonstrate an association between the expression of members of the C/EBP family and the formation of epithelial ovarian tumours, with C/EBPbeta as a potential marker for these tumours. As C/EBPbeta is known to be expressed during proliferation of cells in vitro, it may participate in the proliferative process of ovarian epithelial tumour cells in vivo and play a central role in tumour progression.  (+info)

(2/127) In vitro estrogen-binding by human breast carcinomas.

Patients whose breast carcinomas possess only low concentrations of a receptor molecule that binds estrogens with high affinity are unlikely to respond to hormonal manipulative therapy when the disease recurs. The estrogen-binding capacity of 106 breast carcinomas was measured by an in vitro method and was expressed per milligram wet weight and in some cases related to the concentration of deoxyribonucleic acid (DNA) of the tumours. The ability of tumors to bind 3H-estradiol ranged from 0 to 1.3 fm/mg in pre- and perenopausal women, and from 0 to 16.8 fm/mg in postmenopausal women. Menopausal status or serum concentrations of endogenous estrogen, or both, should therefore be considered when tumours are classified into low and high estrogen-binding capacity. It is not necessary to carry out Scatchard analysis for every tumour, and expressing estradiol binding on the basis of DNA concentration may be preferable to expressing in on a wet-weight basis.  (+info)

(3/127) Serous adenocarcinofibroma of the ovary--report of two cases and review of the literature.

We investigated the clinical and histologic characteristics of patients with ovarian serous adenocarcinofibroma. Because the tumors in both cases contained fibroma components; they were hard and clinically indistinguishable from uterine myoma, even by computed tomography. Both patients experienced relapses associated with tumors that originated outside the abdominal cavity (the subcutaneous abdominal wall in case 1, and the inguinal lymph nodes in case 2). The serum level of CA125 was normal or only moderately elevated at the first onset and relapse. The present cases suggest that the diagnostic features and clinical course differ between ovarian serous adenocarcinoma and serous adenocarcinofibroma.  (+info)

(4/127) Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers.

The DNA base excision repair pathway is responsible for the repair of alkylation and oxidative DNA damage. A crucial step in the base excision repair pathway involves the cleavage of an apurinic/apyrimidinic (AP) site in DNA by an AP endonuclease (APE). The major AP endonuclease in mammalian cells is APE/ref-1, a multifunctional enzyme that acts not only as an AP endonuclease but as a redox-modifying factor for a variety of transcription factors. The purpose of this study was to determine the expression of APE/redox factor-1 (ref-1) in ovarian tissues, particularly ovarian cancers. Formalin-fixed, paraffin-embedded specimens of ovarian tissues (normal, various benign conditions, and epithelial cancers) were studied using both polyclonal and monoclonal antibodies to APE/ref-1. The relationship between APE/ref-1 protein levels and DNA repair activity was studied in ovarian Hey and Hey-C2 cell lines using Western blot and a specific AP-site oligonucleotide cleavage assay. Hey and Hey-C2 cells were fractionated, and the nuclear and cytoplasmic extracts were quantitated for protein levels and assessed for APE/ref-1 with Western blot. Normal ovarian tissues consistently demonstrated strong nuclear staining of the surface epithelium, epithelial inclusions, corpora lutea and albicantia, and stroma. Cytoplasmic staining was absent. A similar pattern was seen for benign conditions including endometriosis. Low malignant potential ovarian cancers stained in a pattern similar to normal ovarian and nonneoplastic tissues; however, two specimens also had areas of cytoplasmic staining. Epithelial ovarian cancers were remarkably different from all other ovarian tissues studied. Both nuclear and cytoplasmic staining of the malignant epithelium were seen and ranged from strong to weak, often with considerable staining heterogeneity within the same tumor. The AP-site oligonucleotide cleavage assay indicated that APE/ref-1 protein levels correlate well with DNA repair activity. The increased levels of APE/ref-1 in the Hey-C2 cells was mainly attributable to increased cytoplasmic enzyme. APE/ref-1 immunoreactivity is altered in malignant ovarian tumors. Further studies will determine whether the altered expression and subcellular location reflect changes in redox regulatory functions.  (+info)

(5/127) Accumulation of collagen in ovarian benign tumours.

Extracellular matrix components of benign ovarian tumours (cystadenoma, adenofibroma, cystadenofibroma) were analysed. The investigated tumours contained twice as much collagen than control ovarian tissues. Significant alterations in mutual quantitative relationships between collagens of various types were observed. The proportion of type I collagen decreased and that of type III collagen increased. The accumulation of collagen was accompanied by a reduction in sulphated glycosaminoglycan content whereas the amount of hyaluronic acid was not changed. Dermatan sulphate was the most abundant glycosaminoglycan component. It is suggested that the accumulation of collagen (natural barrier to the migration of tumour cells) and underexpression of glycosaminoglycans/proteoglycans (binding some growth factors and interleukins) may exert an inhibitory effect on tumour growth.  (+info)

(6/127) Contrast-enhanced sonography in the examination of benign and malignant adnexal masses.

Our objective was to characterize the properties of an intravascular ultrasonographic contrast agent in examination of adnexal masses and to compare contrast agent properties between benign and malignant adnexal tumors. Fifty-eight consecutively examined women with suspected ovarian tumors were examined preoperatively by power Doppler ultrasonography, first without and then with contrast agent enhancement (Levovist). Fourteen women had ovarian cancer, 3 had borderline ovarian tumors, 18 had benign ovarian neoplasms, and 23 had functional adnexal cystic masses or endometriomas. The effect of the contrast agent was evaluated visually and by using computerized power Doppler signal intensity measurements. In visual evaluation, the brightness of the power Doppler signal and the amount of recognizable vascular areas increased in each tumor after contrast agent administration. The number of vessels in power Doppler ultrasonograms, both before and after contrast agent enhancement, was significantly higher in malignant than in benign adnexal masses, as also was the increase in the number of recognizable vessels after contrast agent administration. Contrast agent uptake time was significantly shorter in malignant than in benign tumors. No significant differences were found in the power Doppler signal intensities or their changes between benign and malignant tumors. In conclusion, use of sonographic contrast agent facilitates imaging of tumor vessels. For differentiation of benign and malignant tumors, the kinetic properties of the contrast agent, such as uptake and washout times, may have more potential than the use of the contrast agent in anatomic imaging of the tumor vessels.  (+info)

(7/127) Apparent rat strain-related sensitivity to phorbol promotion of mammary carcinogenesis.

It has been reported that twice-weekly i.p. injections of 4 mg phorbol for 10 weeks, after a single feeding of 6 mg dimethylbenz(a)anthracene (DMBA) in female Wistar rats, led to a significant augmentation of mammary adenocarcinoma incidence and of lymphatic leukemia incidence as compared to 6 mg DMBA alone. In an experiment reported here, in female Sprague-Dawley rats, using the same doses of DMBA and phorbol and the same injection schedule, phorbol given after DMBA did not augment mammary adenocarcinoma incidence or lymphatic leukemia incidence as compared to DMBA given alone. It thus appears that there is a strain-related sensitivity between Wistar and Sprague-Dawley rats with regard to the promoting activity of phorbol when phorbol treatment follows DMBA treatment, and mammary adenocarcinoma incidence and lymphatic leukemia incidence are studied. Further, in Sprague-Dawley rats, phorbol did not promote mammary fibroadenoma incidence in DMBA-treated rats, mammary adenocarcinoma incidence in procarbazine-treated rats, and mammary adenocarcinoma incidence or mammary fibroadenoma incidence in X-ray-treated rats. DMBA and procarbazine, with or without phorbol, tended to induce more mammary neoplasms in the anterior (thoracic) than in the posterior (abdominal) mammary glands. X-irradiation tended to induce mammary neoplasms in approximately equal numbers in the anterior and posterior mammary glands. It was suggested that regional differences in chemically induced mammary carcinogenesis were due to a difference in the transport and delivery of the chemical carcinogens to the regions rather than a difference in the amount of mammary gland tissue in the regions. An analysis of the numbers of Sprague-Dawley rats that developed either no mammary neoplasms, or only mammary adenocarcinomas, or only mammary fibroadenomas, or both mammary adenocarcinomas and mammary fibroadenomas in response to DMBA, procarbazine, and X-ray, suggested that the development of a mammary adenocarcinoma or the development of a mammary fibroadenoma are independent processes.  (+info)

(8/127) Sonographic features of ovarian cystadenofibromas: spectrum of findings.

OBJECTIVE: To describe the sonographic characteristics of ovarian cystadenofibromas. METHODS: We conducted a retrospective study of 23 ovarian tumors histopathologically confirmed as ovarian cystadenofibromas that were preoperatively evaluated by transvaginal color Doppler sonography. RESULTS: In all cases the mass was predominantly cystic. Septations appeared in 30.4% of the tumors. Papillary projections or solid nodules appeared in 56.5% of the cases. The most frequent appearance was a unilocular complex cystic mass. In 47.8% of the tumors, vascularization was detected, having a typical pattern of peripheral vascularization with scattered vessels of high blood flow impedance. CONCLUSIONS: We have described the sonographic spectrum of findings of ovarian cystadenofibromas. The most frequent appearance was a unilocular cystic mass with gross papillary projections or solid nodules. In almost half of the tumors, vascularization could be detected.  (+info)

*  List of MeSH codes (C04)
... adenofibroma MeSH C04.557.450.565.590.595.150 --- brenner tumor MeSH C04.557.450.565.590.595.350 --- fibroadenoma MeSH C04.557. ... adenofibroma MeSH C04.557.470.625.150 --- brenner tumor MeSH C04.557.470.625.350 --- fibroadenoma MeSH C04.557.470.660 --- ...
*  Ovarian cyst
... ovarian cyst Dermoid cyst Ovarian serous cystadenoma Ovarian mucinous cystadenoma Paraovarian cyst Cystic adenofibroma ...
*  International Classification of Diseases for Oncology
NOS Papillary adenofibroma M9014/0 Serous adenofibroma, NOS Serous cystadenofibroma, NOS M9014/1 Serous adenofibroma of ... Malignant serous adenofibroma Serous cystadenocarcinofibroma Malignant serous cystadenofibroma M9015/0 Mucinous adenofibroma, ... NOS M8964/3 Clear cell sarcoma of kidney M8965/0 Nephrogenic adenofibroma M8966/0 Renomedullary interstitial cell tumor ... clear cell cystadenofibroma M8313/1 Clear cell adenofibroma of borderline malignancy Clear cell cystadenofibroma of borderline ...
Adenofibroma edematodes | definition of adenofibroma edematodes by Medical dictionary  Adenofibroma edematodes | definition of adenofibroma edematodes by Medical dictionary
What is adenofibroma edematodes? Meaning of adenofibroma edematodes medical term. What does adenofibroma edematodes mean? ... Looking for online definition of adenofibroma edematodes in the Medical Dictionary? adenofibroma edematodes explanation free. ... adenofibroma edematodes. adenofibroma edematodes. a neoplasm consisting of glandular elements and connective tissue in which ... Adenofibroma edematodes , definition of adenofibroma edematodes by Medical dictionary https://medical-dictionary. ...
more infohttps://medical-dictionary.thefreedictionary.com/adenofibroma+edematodes
Adenofibroma | Define Adenofibroma at Dictionary.com  Adenofibroma | Define Adenofibroma at Dictionary.com
Adenofibroma definition at Dictionary.com, a free online dictionary with pronunciation, synonyms and translation. Look it up ...
more infohttps://www.dictionary.com/browse/adenofibroma
Biliary Adenofibroma with Carcinoma In Situ: A Rare Case Report  Biliary Adenofibroma with Carcinoma In Situ: A Rare Case Report
... N. Thao T. Nguyen,1 Theresa R. Harring,1 Laurie Holley,2 John ... N. Thao T. Nguyen, Theresa R. Harring, Laurie Holley, John A. Goss, and Christine A. O'Mahony, "Biliary Adenofibroma with ...
more infohttps://www.hindawi.com/journals/crihep/2012/793963/cta/
Adenofibroma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials  Adenofibroma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials
MalaCards based summary : Adenofibroma, also known as adenofibroma, no icd-o subtype, is related to clear cell adenofibroma and ... Diseases in the Adenofibroma family:. Malignant Adenofibroma Diseases related to Adenofibroma via text searches within ... MalaCards organs/tissues related to Adenofibroma:. 38 Ovary, Cervix, Uterus, Lung, Testis, Breast, Liver ... Articles related to Adenofibroma:. (show top 50) (show all 122) #. Title. Authors. Year. ...
more infohttp://www.malacards.org/card/adenofibroma
Adenofibroma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials  Adenofibroma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials
Diseases in the Adenofibroma family:. Malignant Adenofibroma Diseases related to Adenofibroma via text searches within ... MalaCards based summary : Adenofibroma, also known as adenofibroma, no icd-o subtype, is related to cystadenofibroma and renal ... MalaCards organs/tissues related to Adenofibroma:. 41 Ovary, Cervix, Uterus, Lung, Testis, Breast, Liver ... Articles related to Adenofibroma:. (show top 50) (show all 125) #. Title. Authors. Year. ...
more infohttps://www.malacards.org/card/adenofibroma?search=actc1
Uterine Corpus Adenofibroma - Semantic Scholar  Uterine Corpus Adenofibroma - Semantic Scholar
Uterine Corpus Adenofibroma. Known as: Adenofibroma of Uterine Body, Corpus Uteri Adenofibroma, Adenofibroma of Uterine Corpus ... Endometrial adenofibroma].. *Khedija Bellil, Slim Haouet, Carole Goutallier Ben Fadhel, Nidhaeddine Kchir, Dalenda Chelli, ... Uterine cervical adenofibroma associated with Turner's syndrome in a young woman. *Osamu Ishiko, Toshiyuki Sumi, Kayoko Ueda, ... Paratesticular adenofibroma is an uncommon benign tumour. Although it has previously been reported in the female reproductive… ...
more infohttps://www.semanticscholar.org/topic/Uterine-Corpus-Adenofibroma/4666117
Adenofibroma  Adenofibroma
... On-line free medical diagnosis assistant. Ranked list of possible diseases from either several symptoms or a full ... Adenofibroma. A benign neoplasm composed of glandular and fibrous tissues, with a relatively large proportion of glands. ( ... Detailed information through a personalized searchRanked list of diseases related to "Adenofibroma"Drugs, active principles and ... "Adenofibroma"Medicinal plantsQuestions and answers from other usersNewsVideos ...
more infohttps://lookfordiagnosis.com/mesh_info.php?term=Adenofibroma&lang=1
Pathogenesis of Ovarian Clear Cell Adenofibroma, Atypical Proliferative (Borderline) Tumor, and Carcinoma: Clinicopathologic...  Pathogenesis of Ovarian Clear Cell Adenofibroma, Atypical Proliferative (Borderline) Tumor, and Carcinoma: Clinicopathologic...
Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary: a possible alternative ovarian ... clear-cell adenofibroma-associated pathway. Virchows Arch. 2009;455:261-270 74. Yamamoto S, Tsuda H, Takano M. et al. ... Adenofibroma (n=4). Atypical proliferative (borderline) tumor (n=41). Mean patient age (years) [range]. 61 (50-75). 60 (30-85) ... Clear Cell Adenofibroma (n=4). The clinicopathologic features with respect to age, stage, bilaterality, tumor size, and gross ...
more infohttp://www.jcancer.org/v02p0094.htm
Imaging Features of Carcinosarcoma Arising from Adenofibroma  Imaging Features of Carcinosarcoma Arising from Adenofibroma
Adenofibroma is a benign tumor composed histologically of epithelial elements and mesenchymal stroma. Carcinosarcoma is a ... Adenofibroma, Carcinosarcoma, Malignant transformation of adenofibroma, Magnetic resonance imaging. Affiliation:. Department of ... Carcinosarcoma arising from adenofibroma of the uterus has never been reported in the English literature. We report a case of a ... Imaging Features of Carcinosarcoma Arising from Adenofibroma of the Uterus: A Case Report Author(s):. Jiyun Oh, Sung Bin Park ...
more infohttp://www.currentmedicalimagingreviews.com/articles/175156/imaging-features-of-carcinosarcoma-arising-from-adenofibroma-of-the-uterus-a-case-report
Solitary fibrous pseudopapillary tumor of the lung: pulmonary fibroadenoma and adenofibroma revisited]. | Docphin  Solitary fibrous pseudopapillary tumor of the lung: pulmonary fibroadenoma and adenofibroma revisited]. | Docphin
Solitary fibrous pseudopapillary tumor of the lung: pulmonary fibroadenoma and adenofibroma revisited]. A Cavazza G Rossi L De ... corresponding to what has been reported in the literature as pulmonary adenofibroma and fibroadenoma. The most important ...
more infohttps://www.docphin.com/research/article-detail/8220469/PubMedID-12968312/%5BSolitary-fibrous-pseudopapillary-tumor-of-the-lung-pulmonary-fibroadenoma-and-adenofibroma-revisited%5D
Benign Cervical Lesions: Embryology, Anatomy, Physiology  Benign Cervical Lesions: Embryology, Anatomy, Physiology
Papillary adenofibroma. This neoplasm is uncommon. Grossly, it appears as a polypoid structure. On ultrasound, cystic areas ... Haberal A, Cil AP, Gunes M, Cavusoglu D. Papillary adenofibroma of the cervix: A case report. Ultrasound Obstet Gynecol. Aug ...
more infohttps://emedicine.medscape.com/article/264966-overview
Benign Tumours Flashcards by  | Brainscape  Benign Tumours Flashcards by | Brainscape
Adenofibroma.. -Brenner's tumour:. -Over 95% are benign and more than 90% are unilateral.. They may be associated with mucinous ...
more infohttps://www.brainscape.com/flashcards/benign-tumours-6677399/packs/10479931
Do Women Have A Prostate Cancer? This Is The Answer - TheAppside  Do Women Have A Prostate Cancer? This Is The Answer - TheAppside
Adenofibroma.. An adenofibroma is a noncancerous development. It's generally discovered on fibrous and glandular tissue. In a ... case report of an adenofibroma of the female prostate, the growth triggered discomfort during sexual relations. Surgical ...
more infohttps://theappside.com/do-women-have-a-prostate/
https://www.medicalnewstoday.com/articles/319202.php  https://www.medicalnewstoday.com/articles/319202.php
adenofibroma or fibroadenoma. *fatty lumps made of bruised, dead, or injured mammary fat cells ...
more infohttps://www.medicalnewstoday.com/articles/319202.php
CALB2 Gene - GeneCards | CALB2 Protein | CALB2 Antibody  CALB2 Gene - GeneCards | CALB2 Protein | CALB2 Antibody
Diseases associated with CALB2 include Adenomatoid Tumor and Adenofibroma. GO annotations related to this gene include calcium ...
more infohttp://www.genecards.org/cgi-bin/carddisp.pl?gene=CALB2
Fibroadenosis of breast treatment - New Doctor Insights  Fibroadenosis of breast treatment - New Doctor Insights
What is the treatment of adenofibroma in the breast? Dr. Regina Hampton Dr. Hampton ...
more infohttps://www.healthtap.com/topics/fibroadenosis-of-breast-treatment
PDLIM5 Gene - GeneCards | PDLI5 Protein | PDLI5 Antibody  PDLIM5 Gene - GeneCards | PDLI5 Protein | PDLI5 Antibody
Diseases associated with PDLIM5 include Nephrogenic Adenofibroma and Nail-Patella Syndrome. Among its related pathways are ...
more infohttps://www.genecards.org/cgi-bin/carddisp.pl?gene=PDLIM5
Liver/Gallbladder  Liver/Gallbladder
We report a case of biliary adenofibroma in a 47-year-old woman, who presented with right upper quadrant pain for several ... Biliary adenofibroma: a rare neoplasm of bile duct origin with an indolent behavior. ... that biliary adenofibroma originates from interlobular or larger bile ducts. Three years after a subtotal resection no ... biliary adenofibroma may represent a premalignant process that warrants complete resection and thorough histopathologic ...
more infohttp://thedoctorsdoctor.com/bodysites/liver_gallbladder.htm
Gynecologic and Obstetric Pathology. A Volume in the High Yield Pathology Series  Gynecologic and Obstetric Pathology. A Volume in the High Yield Pathology Series
Endometrioid adenofibroma. 252. Proliferative (borderline) endodometrioid adenofibroma. 253. Mullerian mucinous and ... Borderline clear cell adenofibroma. 259. Metastatic carcinoma to the ovary. 260. Pseudomyxoma peritonei. C. Germ Cell Tumors. ... Adenofibroma. 219. Benign epithelial hyperplasia (secretory cell outgrowths). 219A. p53 signatures 219B. Low grade serous tubal ...
more infohttps://www.researchandmarkets.com/reports/3689012/gynecologic-and-obstetric-pathology-a-volume-in
Application # 2017/0102386. Method for identifying and obtaining activated T-cells that have a
     demethylated Foxp3 TSDR...  Application # 2017/0102386. Method for identifying and obtaining activated T-cells that have a demethylated Foxp3 TSDR...
... adenofibroma; adenolymphoma; carcinosarcoma, chordoma, craniopharyngioma, dysgerminoma, hamartoma; mesenchymoma; mesonephroma, ...
more infohttp://patents.com/us-20170102386.html